Target intelligence / Profile preview

Chromatin (DNA and associated proteins)

Molecular classification
Nucleic acid, Histone modification, Transcription factor, Other
01

Overview

Chromatin is the complex of DNA and associated proteins, primarily histones, that organizes the eukaryotic genome within the cell nucleus (National Human Genome Research Institute). Its primary biological function is to package long DNA molecules into compact structures, protecting the genetic code and regulating access for vital processes such as replication, transcription, and repair (Nature Reviews Molecular Cell Biology). In many diseases, particularly oncology, the structural integrity and epigenetic state of chromatin are frequently dysregulated, contributing to uncontrolled cell proliferation and genomic instability (Nature Reviews Cancer). This target complex is the focus of numerous therapeutic interventions; for example, cytotoxic chemotherapies like platinum-based agents and alkylators bind directly to DNA, while other agents target the proteins that manage DNA topology or histone modifications (NIH/NCI Dictionary of Cancer Terms). Because these structures are fundamental to the survival of all dividing cells, therapeutic targeting often involves a narrow therapeutic window and significant safety concerns, including myelosuppression and the risk of secondary cancers (American Cancer Society).

Other names
Nucleoprotein complexNucleosomeGenomic DNAChromosomeDNA-protein complex
02

Mechanism of action

Drugs targeting this complex function through DNA alkylation and cross-linking, intercalation between base pairs to disrupt replication, inhibition of topoisomerase enzymes to induce double-strand breaks, or modulation of histone-modifying enzymes to alter the epigenetic state of the genome (StatPearls, 'Chemotherapy Mechanism of Action', 2023).

03

Biological functions

DNA replicationGene expression regulationDNA repairInformation storageCell division
04

Disease associations

CancerAutoimmune diseaseGenetic disorderInfection
05

Safety considerations

MyelosuppressionSecondary malignanciesTeratogenicityMutagenicityCardiotoxicity
06

Interacting drugs

Cisplatin

6 more in the full profile.

07

Biomarkers

Microsatellite instability (MSI)Tumor mutational burden (TMB)gamma-H2AX (DNA damage marker)Histone acetylation levels

Beyond the preview

Go deeper on Chromatin (DNA and associated proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromatin (DNA and associated proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call